Does age or surgical setting affect long-term anti-seizure medication discontinuation after ganglioglioma surgery in children and adults?
Older age is negatively associated with the ability to discontinue anti-seizure medications long-term after ganglioglioma surgery, regardless of whether the surgery was performed in a specialized epilepsy program.
This study demonstrates that long-term ASM discontinuation after ganglioglioma surgery is negatively associated with increasing age. ASM discontinuation is the same for those undergoing surgery in an epilepsy surgery program as for those who do not. Future studies are needed to explore why older patients are less likely to discontinue ASM treatment after ganglioglioma surgery.
Grubor et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: